# Brain Canada

> Brain Canada is a VC fund in Montreal backing Health Care, Biotechnology and Medical. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Montreal, Canada
- Total investments: 4
- Last investment: Oct 2024
- Lead investor: 25%
- Last updated: Aug 2026
- X (Twitter): https://www.twitter.com/braincanada
- Website: http://www.braincanada.ca

Brain Canada is a VC fund in Montreal focused on Health Care and Biotechnology. Brain Canada supports collaborative, multi disciplinary, multi-institutional research across the neurosciences.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 50% |
| Biotechnology | 2 | 50% |
| Medical | 1 | 25% |
| Wellness | 1 | 25% |
| Education | 1 | 25% |

13 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Grant | 3 | 75% |
| Funding Round | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| NeuroTracker | With over 40 peer-reviewed studies built upon 20 years of research in neuroscience, NeuroTracker is the World's number one, most scientifically validated Cognitive Training System. Our proven efficacy and patented system have established NeuroTracker as a valuable tool, widely used by clinicians and therapists in neurovision and rehabilitationmarkets.NeuroTracker is designed to uniquely measure and enhance high-level cognitive function of neural networks that govern situational awareness, attention, executive function and cognitive stamina. Used by elite athletes, military special forces, pilots, professional gamers, and students to increase awareness potential for heightened mental performance and improved cognitive ability.NeuroTracker transforms lives, whatever the starting point is. | $2M | Grant | Oct 31, 2024 |  |
| McGill University | McGill University is one of Canada's best-known institutions of higher learning and one of the leading universities in the world. With students coming to McGill from some 150 countries, our student body is the most internationally diverse of any research-intensive university in the country. McGill was founded in 1821 thanks to a generousbequest by James McGill, and since then, we've grown from a small college to a bustling university with two campuses, 11 faculties, some 300 programs of study, and more than 37,500 students. The University also partners with four affiliated teaching hospitals to graduate over 1,000 health care professionals each year.In addition to a stellar faculty, McGill is known for attracting the brightest students from across Canada, the United States, and around the world. McGill students have the highest average entering grades in Canada, and our commitment to fostering the very best has helped our students win more national and international awards on average than their peers at any other Canadian university. The prestigious Rhodes Scholarship has gone to a nation-leading 136 McGill students. | $1.6M | Grant | Jul 03, 2024 |  |
| BioMark Diagnostics | BioMark is an oncology-focused company with advanced near-to- market diagnostic technologies designed to improve patient outcomes. They have developed and own multiple intellectual properties (IPs) in detection and quantitation of metabolites.They hand-picked a proven, global enterprise team of scientists, engineers and medical professionals tohelp commercialize their innovative technology and to increase prediction and accuracy in the diagnosis of cancers by following and incorporating the highest regulatory ,clinical and scientific standards.. Their cross pollinated, balanced and committed team was established in 2007. Their mission is to develop and commercialize innovative technologies to increase prediction and accuracy in diagnosis of cancers. | $683.4K | Grant | Jun 01, 2021 |  |
| KalGene Pharmaceuticals | KalGene Pharmaceuticals, Inc. is a privately held company working in partnership with many of North America and Europe’s leading clinician-scientists and academic institutions. KalGene is focused on the development of targeted therapeutics and companion diagnostics. Its programs are aimed at improving clinical and survival outcomes through the useof personalized medicine. Personalized medicine seeks to predict which patients will respond to a particular therapy in advance of treatment. This prediction allows physicians to prescribe treatment according to an individual’s specific biological signature, or needs. | $1.5M |  | Jun 08, 2015 |  |

4 of 4 investments shown.

## Co-investors
- [Canadian Institutes of Health Research](https://shizune.co/investors/profile/canadian-institutes-of-health-research) — VC Fund, 2 deals together
- [CQDM](https://shizune.co/investors/profile/cqdm) — VC Fund, 2 deals together
- [Canadian Cancer Society](https://shizune.co/investors/profile/canadian-cancer-society) — VC Fund, 1 deal together
- [Delmar Chemicals](https://shizune.co/investors/profile/delmar-chemicals) — VC Fund, 1 deal together
- [Government Of Quebec](https://shizune.co/investors/profile/government-of-quebec) — VC Fund, 1 deal together
- [MEDTEQ+](https://shizune.co/investors/profile/medteq) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Scottish Enterprise](https://shizune.co/investors/profile/scottish-enterprise) — VC Fund
- [Foundation for Innovation and Technology (FIT)](https://shizune.co/investors/profile/foundation-pour-l-innovation-technologique) — VC Fund
- [Business Finland](https://shizune.co/investors/profile/tekes) — VC Fund

## FAQ

### What does Brain Canada invest in?

Brain Canada invests primarily in Health Care, Biotechnology and Medical startups, most often at Grant and Funding Round stage. Most of the 4 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Brain Canada last invest?

The most recent investment recorded for Brain Canada closed in Oct 2024. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co